Global Lisavanbulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Lisavanbulin Market Growth (Status and Outlook) 2025-2031

The global Lisavanbulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Lisavanbulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Lisavanbulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Lisavanbulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Lisavanbulin players cover Glixx Labs Inc, Excenen Pharmatech, Basilea Pharmaceutica, MedKoo Biosciences, MuseChem, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LPI (LP Information) newest research report, the Lisavanbulin Industry Forecast looks at past sales and reviews total world Lisavanbulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Lisavanbulin sales for 2025 through 2031. With Lisavanbulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lisavanbulin industry. This Insight Report provides a comprehensive analysis of the global Lisavanbulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lisavanbulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Lisavanbulin market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lisavanbulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lisavanbulin. This report presents a comprehensive overview, market shares, and growth opportunities of Lisavanbulin market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 0.98 &nbsp;&nbsp;&nbsp; 0.99 &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Recurrent Glioblastoma &nbsp;&nbsp;&nbsp; Advanced Solid Tumor &nbsp;&nbsp;&nbsp; Refractory Ovarian Cancer &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Glixx Labs Inc &nbsp;&nbsp;&nbsp; Excenen Pharmatech &nbsp;&nbsp;&nbsp; Basilea Pharmaceutica &nbsp;&nbsp;&nbsp; MedKoo Biosciences &nbsp;&nbsp;&nbsp; MuseChem &nbsp;&nbsp;&nbsp; Smolecole

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Lisavanbulin Market Size (2020-2031) &nbsp;2.1.2 Lisavanbulin Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Lisavanbulin by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Lisavanbulin Segment by Type &nbsp;2.2.1 0.98 &nbsp;2.2.2 0.99 &nbsp;2.2.3 Others &nbsp;2.3 Lisavanbulin Market Size by Type &nbsp;2.3.1 Lisavanbulin Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Lisavanbulin Market Size Market Share by Type (2020-2025) &nbsp;2.4 Lisavanbulin Segment by Application &nbsp;2.4.1 Recurrent Glioblastoma &nbsp;2.4.2 Advanced Solid Tumor &nbsp;2.4.3 Refractory Ovarian Cancer &nbsp;2.4.4 Others &nbsp;2.5 Lisavanbulin Market Size by Application &nbsp;2.5.1 Lisavanbulin Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Lisavanbulin Market Size Market Share by Application (2020-2025) 3 Lisavanbulin Market Size by Player &nbsp;3.1 Lisavanbulin Market Size Market Share by Player &nbsp;3.1.1 Global Lisavanbulin Revenue by Player (2020-2025) &nbsp;3.1.2 Global Lisavanbulin Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Lisavanbulin Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Lisavanbulin by Region &nbsp;4.1 Lisavanbulin Market Size by Region (2020-2025) &nbsp;4.2 Global Lisavanbulin Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Lisavanbulin Market Size Growth (2020-2025) &nbsp;4.4 APAC Lisavanbulin Market Size Growth (2020-2025) &nbsp;4.5 Europe Lisavanbulin Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Lisavanbulin Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Lisavanbulin Market Size by Country (2020-2025) &nbsp;5.2 Americas Lisavanbulin Market Size by Type (2020-2025) &nbsp;5.3 Americas Lisavanbulin Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Lisavanbulin Market Size by Region (2020-2025) &nbsp;6.2 APAC Lisavanbulin Market Size by Type (2020-2025) &nbsp;6.3 APAC Lisavanbulin Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Lisavanbulin Market Size by Country (2020-2025) &nbsp;7.2 Europe Lisavanbulin Market Size by Type (2020-2025) &nbsp;7.3 Europe Lisavanbulin Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Lisavanbulin by Region (2020-2025) &nbsp;8.2 Middle East & Africa Lisavanbulin Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Lisavanbulin Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Lisavanbulin Market Forecast &nbsp;10.1 Global Lisavanbulin Forecast by Region (2026-2031) &nbsp;10.1.1 Global Lisavanbulin Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Lisavanbulin Forecast &nbsp;10.1.3 APAC Lisavanbulin Forecast &nbsp;10.1.4 Europe Lisavanbulin Forecast &nbsp;10.1.5 Middle East & Africa Lisavanbulin Forecast &nbsp;10.2 Americas Lisavanbulin Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Lisavanbulin Forecast &nbsp;10.2.2 Canada Market Lisavanbulin Forecast &nbsp;10.2.3 Mexico Market Lisavanbulin Forecast &nbsp;10.2.4 Brazil Market Lisavanbulin Forecast &nbsp;10.3 APAC Lisavanbulin Forecast by Region (2026-2031) &nbsp;10.3.1 China Lisavanbulin Market Forecast &nbsp;10.3.2 Japan Market Lisavanbulin Forecast &nbsp;10.3.3 Korea Market Lisavanbulin Forecast &nbsp;10.3.4 Southeast Asia Market Lisavanbulin Forecast &nbsp;10.3.5 India Market Lisavanbulin Forecast &nbsp;10.3.6 Australia Market Lisavanbulin Forecast &nbsp;10.4 Europe Lisavanbulin Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Lisavanbulin Forecast &nbsp;10.4.2 France Market Lisavanbulin Forecast &nbsp;10.4.3 UK Market Lisavanbulin Forecast &nbsp;10.4.4 Italy Market Lisavanbulin Forecast &nbsp;10.4.5 Russia Market Lisavanbulin Forecast &nbsp;10.5 Middle East & Africa Lisavanbulin Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Lisavanbulin Forecast &nbsp;10.5.2 South Africa Market Lisavanbulin Forecast &nbsp;10.5.3 Israel Market Lisavanbulin Forecast &nbsp;10.5.4 Turkey Market Lisavanbulin Forecast &nbsp;10.6 Global Lisavanbulin Forecast by Type (2026-2031) &nbsp;10.7 Global Lisavanbulin Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Lisavanbulin Forecast 11 Key Players Analysis &nbsp;11.1 Glixx Labs Inc &nbsp;11.1.1 Glixx Labs Inc Company Information &nbsp;11.1.2 Glixx Labs Inc Lisavanbulin Product Offered &nbsp;11.1.3 Glixx Labs Inc Lisavanbulin Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Glixx Labs Inc Main Business Overview &nbsp;11.1.5 Glixx Labs Inc Latest Developments &nbsp;11.2 Excenen Pharmatech &nbsp;11.2.1 Excenen Pharmatech Company Information &nbsp;11.2.2 Excenen Pharmatech Lisavanbulin Product Offered &nbsp;11.2.3 Excenen Pharmatech Lisavanbulin Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Excenen Pharmatech Main Business Overview &nbsp;11.2.5 Excenen Pharmatech Latest Developments &nbsp;11.3 Basilea Pharmaceutica &nbsp;11.3.1 Basilea Pharmaceutica Company Information &nbsp;11.3.2 Basilea Pharmaceutica Lisavanbulin Product Offered &nbsp;11.3.3 Basilea Pharmaceutica Lisavanbulin Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Basilea Pharmaceutica Main Business Overview &nbsp;11.3.5 Basilea Pharmaceutica Latest Developments &nbsp;11.4 MedKoo Biosciences &nbsp;11.4.1 MedKoo Biosciences Company Information &nbsp;11.4.2 MedKoo Biosciences Lisavanbulin Product Offered &nbsp;11.4.3 MedKoo Biosciences Lisavanbulin Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 MedKoo Biosciences Main Business Overview &nbsp;11.4.5 MedKoo Biosciences Latest Developments &nbsp;11.5 MuseChem &nbsp;11.5.1 MuseChem Company Information &nbsp;11.5.2 MuseChem Lisavanbulin Product Offered &nbsp;11.5.3 MuseChem Lisavanbulin Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 MuseChem Main Business Overview &nbsp;11.5.5 MuseChem Latest Developments &nbsp;11.6 Smolecole &nbsp;11.6.1 Smolecole Company Information &nbsp;11.6.2 Smolecole Lisavanbulin Product Offered &nbsp;11.6.3 Smolecole Lisavanbulin Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Smolecole Main Business Overview &nbsp;11.6.5 Smolecole Latest Developments 12 Research Findings and Conclusion

Buyer Information

Order Summary

Report	Global Lisavanbulin Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI39595